Pharvaris N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports the results of the Annual General Meeting of Shareholders held by Pharvaris N.V. on June 27, 2025. The filing covers corporate governance actions and the ratification of financial statements for the fiscal year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document confirms that shareholders adopted the Dutch statutory annual accounts for the fiscal year ended December 31, 2024, but does not detail the figures within those accounts.
Material Changes and Corporate Actions
- Auditor Appointment: Shareholders appointed PricewaterhouseCoopers Accountants N.V. as the external independent auditor for the fiscal year ending December 31, 2025.
- Director Discharge: Directors were discharged from liability regarding their performance of duties during the fiscal year ended December 31, 2024.
- Share Repurchase Authorization: Shareholders extended the Board's authorization to acquire shares and depository receipts.
- Board Re-appointments: Dr. Meeker, Dr. Glassman, and Ms. Monges were re-appointed as non-executive directors.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a record of shareholder voting outcomes.
Key Facts for Investor Verification
- Verify the specific financial figures in the adopted Dutch statutory annual accounts for the year ended December 31, 2024, as they are not listed in this filing.
- Confirm the terms and limits of the extended share repurchase authorization.
- Review the full annual report to assess the company's financial health and operational progress for 2024.